FGF23 and chronic kidney disease: Another limitation is that the population of our current study, elderly subjects with cardiovascular history and CKD, differs in several aspects from the renal transplant population in which we initially identified the association between n-3 fatty acid intake and FGF23 levels [13], among others in terms of cardiovascular history and medication use (particularly immunosuppressive medication), although renal function was comparable among both studies.